-
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
-
The Affordable Care Act’s Impact on Access to Cancer CareA study at the AACR Cancer Health Disparities Conference found more people got quality cancer care after the ACA went into effect.
by Cancer Research Catalyst
-
What Is Liquid Biopsy?Blood tests, often called liquid biopsy, could be key to early cancer detection and monitoring response to treatment.
by Cancer Research Catalyst
-
The More You Know About Cancer PreventionStudies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce benefits from these tactics.
by Cancer Research Catalyst
-
Some Breast Cancer Patients May Safely Skip RadiationThree presentations at SABCS in December find that it may be safe in certain cases for people with breast cancer to go without radiation.
by Cancer Research Catalyst
Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles
Understanding How High and Low Testosterone Levels Can Treat Prostate CancerUsing high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
